Blood Pressure Effects of Monoamine Oxidase Inhibitors — the Highs and Lows*
- 1 December 1987
- journal article
- case report
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 32 (9) , 803-808
- https://doi.org/10.1177/070674378703200915
Abstract
Clinical guidelines for the management of the most common side effects associated with monoamine oxidase inhibitors (postural hypotension and hypertensive episodes) are offered. When non-pharmacological interventions fail to alleviate MAOI induced postural hypotension, the use of volume expanders (salt tablets or fludrocortisone) may be effective alternatives to drug discontinuation. Phentolamine and chlorpromazine are traditional drug treatments for MAOI hypertensive emergencies. The newer drug treatments evolved in the last decade for treating hypertensive emergencies is not reflected in the psychiatric or emergency medicine literature on treating MAOI induced hypertensive states. Nifedipine, diazoxide, or sodium nitroprusside appear to be more rational choices for this problem.Keywords
This publication has 46 references indexed in Scilit:
- Dietary salt and blood pressurePreventive Medicine, 1983
- Adverse Effects of Antidepressant Drugs Part 1Drugs, 1981
- Phenelzine and Amitriptyline in the Treatment of DepressionArchives of General Psychiatry, 1980
- Studies on the Mechanism of Mineralocorticoid-Induced Blood Pressure Increase in ManClinical Science, 1979
- CLINICAL CHARACTERISTICS OF IMIPRAMINE-INDUCED ORTHOSTATIC HYPOTENSIONThe Lancet, 1979
- HAZARDS WITH MONOAMINE-OXIDASE INHIBITORS: A PERSISTENT PROBLEMThe Lancet, 1978
- Therapeutic experience with fludrocortisone in diabetic postural hypotension.BMJ, 1976
- Towards Rational Therapy with Monoamine Oxidase InhibitorsThe British Journal of Psychiatry, 1976
- Management of Postural HypotensionBMJ, 1970
- Successful Treatment of Orthostatic Hypotension with 9-Alpha-FluorohydrocortisoneNew England Journal of Medicine, 1959